The role of record linkage in post-marketing drug surveillance.
Open Access
- 1 February 1986
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 22 (S1), 77S-82S
- https://doi.org/10.1111/j.1365-2125.1986.tb02987.x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Postmarketing drug surveillance by record linkage in Tayside.Journal of Epidemiology and Community Health, 1984
- Medicaid Drug‐event Data: An Emerging Tool for Evaluation of Drug RiskActa Medica Scandinavica, 1984
- Post-marketing surveillance: how many patients?Trends in Pharmacological Sciences, 1981
- Postmarketing surveillance of adverse drug reactions in general practice. I: search for new methods.BMJ, 1981
- Vaginal Spermicides and Congenital DisordersJAMA, 1981
- Record linkage for drug monitoring.Journal of Epidemiology and Community Health, 1981
- Postmarketing Surveillance of New Drugs: I. Review of Objectives and MethodologyThe Journal of Clinical Pharmacology, 1979
- Replacement Estrogens and Endometrial CancerNew England Journal of Medicine, 1979
- Screening criteria for drug monitoring The kaiser-permanente drug reaction monitoring systemJournal of Chronic Diseases, 1972
- Experience in Monitoring Drug Reactions in OutpatientsPublished by American Medical Association (AMA) ,1971